Previous Article | Next Article 
Journal of Clinical Microbiology, March 1999, p. 700-705, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
In Vitro Culture and Drug Sensitivity Assay of
Plasmodium falciparum with Nonserum Substitute and
Acute-Phase Sera
Pascal
Ringwald,*
Fleurette Solange
Meche,
Jean
Bickii, and
Leonardo K.
Basco
Laboratoire de Recherches sur le Paludisme,
Laboratoire Associé Francophone 302, Organisation de Coordination
pour la lutte contre les Endémies en Afrique Centrale, and
Institut Français de Recherche Scientifique pour le
Développement en Coopération, Yaoundé, Cameroon
Received 5 June 1998/Returned for modification 9 November
1998/Accepted 2 December 1998
The short-term in vitro growth of Plasmodium falciparum
parasites in the asexual erythrocytic stage and the in vitro activities of eight standard antimalarial drugs were assessed and compared by
using RPMI 1640 medium supplemented with 10% nonimmune human serum,
10% autologous or homologous acute-phase serum, or 0.5% Albumax I
(lipid-enriched bovine serum albumin). In general, parasite growth was
maximal with autologous (or homologous) serum, followed by Albumax I
and nonimmune serum. The 50% inhibitory concentrations (IC50s) varied widely, depending on the serum or serum
substitute. The comparison of IC50s between assays with
autologous and nonimmune sera showed that monodesethylamodiaquine,
halofantrine, pyrimethamine, and cycloguanil had similar
IC50s. Although the IC50s of chloroquine, monodesethylamodiaquine, and dihydroartemisinin were similar with Albumax I and autologous sera, the IC50s of all test
compounds obtained with Albumax I differed considerably from the
corresponding values obtained with nonimmune serum. Our results suggest
that Albumax I and autologous and homologous sera from symptomatic, malaria-infected patients may be useful alternative sources of serum
for in vitro culture of P. falciparum isolates in the
field. However, autologous sera and Albumax I do not seem to be
suitable for the standardization of isotopic in vitro assays for all
antimalarial drugs.
*
Corresponding author. Mailing address: OCEAC/ORSTOM,
B.P. 288, Yaoundé, Cameroon. Phone: (237) 232 232. Fax: (237) 230 061. E-mail: oceac{at}camnet.cm.
Journal of Clinical Microbiology, March 1999, p. 700-705, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Reininger, L., Tewari, R., Fennell, C., Holland, Z., Goldring, D., Ranford-Cartwright, L., Billker, O., Doerig, C.
(2009). An Essential Role for the Plasmodium Nek-2 Nima-related Protein Kinase in the Sexual Development of Malaria Parasites. J. Biol. Chem.
284: 20858-20868
[Abstract]
[Full Text]
-
Dorin-Semblat, D., Sicard, A., Doerig, C., Ranford-Cartwright, L., Doerig, C.
(2008). Disruption of the PfPK7 Gene Impairs Schizogony and Sporogony in the Human Malaria Parasite Plasmodium falciparum. Eukaryot Cell
7: 279-285
[Abstract]
[Full Text]
-
Singh, K., Agarwal, A., Khan, S. I., Walker, L. A., Tekwani, B. L.
(2007). Growth, Drug Susceptibility, and Gene Expression Profiling of Plasmodium falciparum Cultured in Medium Supplemented with Human Serum. J Biomol Screen
12: 1109-1114
[Abstract]
-
Frankland, S., Elliott, S. R., Yosaatmadja, F., Beeson, J. G., Rogerson, S. J., Adisa, A., Tilley, L.
(2007). Serum Lipoproteins Promote Efficient Presentation of the Malaria Virulence Protein PfEMP1 at the Erythrocyte Surface. Eukaryot Cell
6: 1584-1594
[Abstract]
[Full Text]
-
BASCO, L. K.
(2006). MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXIII. EXPERIMENTAL STUDIES ON SERUM SUBSTITUTES AND ALTERNATIVE CULTURE MEDIA FOR IN VITRO DRUG SENSITIVITY ASSAYS USING CLINICAL ISOLATES OF PLASMODIUM FALCIPARUM. Am J Trop Med Hyg
75: 777-782
[Abstract]
[Full Text]
-
Frankland, S., Adisa, A., Horrocks, P., Taraschi, T. F., Schneider, T., Elliott, S. R., Rogerson, S. J., Knuepfer, E., Cowman, A. F., Newbold, C. I., Tilley, L.
(2006). Delivery of the Malaria Virulence Protein PfEMP1 to the Erythrocyte Surface Requires Cholesterol-Rich Domains. Eukaryot Cell
5: 849-860
[Abstract]
[Full Text]
-
NOEDL, H., ATTLMAYR, B., WERNSDORFER, W. H., KOLLARITSCH, H., MILLER, R. S.
(2004). A HISTIDINE-RICH PROTEIN 2-BASED MALARIA DRUG SENSITIVITY ASSAY FOR FIELD USE. Am J Trop Med Hyg
71: 711-714
[Abstract]
[Full Text]
-
BASCO, L. K.
(2004). MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XX. EXPERIMENTAL STUDIES ON VARIOUS FACTORS OF IN VITRO DRUG SENSITIVITY ASSAYS USING FRESH ISOLATES OF PLASMODIUM FALCIPARUM. Am J Trop Med Hyg
70: 474-480
[Abstract]
[Full Text]
-
Ancelin, M. L., Calas, M., Vidal-Sailhan, V., Herbute, S., Ringwald, P., Vial, H. J.
(2003). Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial Activities. Antimicrob. Agents Chemother.
47: 2590-2597
[Abstract]
[Full Text]
-
BASCO, L. K.
(2003). MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XV. EXPERIMENTAL STUDIES ON SERUM SUBSTITUTES AND SUPPLEMENTS AND ALTERNATIVE CULTURE MEDIA FOR IN VITRO DRUG SENSITIVITY ASSAYS USING FRESH ISOLATES OF PLASMODIUM FALCIPARUM. Am J Trop Med Hyg
69: 168-173
[Abstract]
[Full Text]
-
Rager, N., Mamoun, C. B., Carter, N. S., Goldberg, D. E., Ullman, B.
(2001). Localization of the Plasmodium falciparum PfNT1 Nucleoside Transporter to the Parasite Plasma Membrane. J. Biol. Chem.
276: 41095-41099
[Abstract]
[Full Text]